Research map: Real‐World Prognostic Analysis of Clinical Characteristics in Extensive‐Stage Small Cell Lung Cancer: A Nomogram for Survival Prediction in Patients Receiving First‐Line Immunochemotherapy With Serplulimab

Back to the article

Papers in this map

  1. First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer · Leora Horn · 2018 · 3642 citations · Cited by this paper
  2. Association of the Affordable Care Act With Receipt of Guideline‐Concordant Adjuvant Chemotherapy for Colon and Non‐Small Cell Lung Cancer · 2026 · Related
  3. Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic · Timothy An-thy Chan · 2018 · 2934 citations · Cited by this paper
  4. Predicting Poor Efficacy of Cabozantinib in Advanced Renal Cell Carcinoma by Exploratory Metabolic Pathway Analysis and In Vitro Verification · 2026 · Related
  5. Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data · Charles M. Rudin · 2019 · 1339 citations · Cited by this paper
  6. Comparative Cardiovascular Safety and Exploratory Bleeding Outcomes of Ibrutinib, Acalabrutinib, and Zanubrutinib in Mantle Cell Lymphoma: A Propensity Score‐Matched Real‐World Analysis · 2026 · Related
  7. Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities · Carl Michael Gay · 2021 · 990 citations · Cited by this paper
  8. The Impact of the G8 Score on Survival Outcomes in Patients With Head and Neck Cancer Undergoing Concurrent Radiotherapy With Cetuximab due to Contraindications With Cisplatin · 2026 · Related
  9. Survival changes in patients with small cell lung cancer and disparities between different sexes, socioeconomic statuses and ages · Shuncong Wang · 2017 · 241 citations · Cited by this paper
  10. The Zuo Jin Wan Formula Reverses Cisplatin Resistance in Gastric Cancer by Inhibiting the Mitochondrial Translocation of Dynamin‐Related Protein 1 and Its Mediated Mitochondrial Fission and Mitophagy · 2026 · Related
  11. Expression and clinical significance of PD-L1, B7-H3, B7-H4 and TILs in human small cell lung Cancer (SCLC) · Daniel Carvajal‐Hausdorf · 2019 · 214 citations · Cited by this paper
  12. Notch3/4 Knockdown Inhibits Colon Adenocarcinoma Progression by Suppressing Tumor Cell Activity and Orchestrating VEGFA ‐Dependent Tumor Immune Microenvironment · 2026 · Related
  13. Systemic Immune–Inflammation Index Predicts Prognosis of Cancer Immunotherapy: Systemic Review and Meta-Analysis · Bao‐Wen Tian · 2022 · 137 citations · Cited by this paper
  14. Overcoming Radiation Resistance: Ferroptosis Induction to Sensitize Solid Tumors to Radiation Therapy · 2026 · Related
  15. Prognostic significance of serum LDH in small cell lung cancer: A systematic review with meta-analysis · Xiuxiu Zhang · 2016 · 121 citations · Cited by this paper
  16. Inhibition of the Metalloproteinase ADAMTS5 Suppresses Colorectal Cancer Metastasis via the PEDF /Wnt/β‐Catenin Pathway · 2026 · Related
  17. Assessment of systematic inflammatory and nutritional indexes in extensive-stage small-cell lung cancer treated with first-line chemotherapy and atezolizumab · Wei-Xiang Qi · 2021 · 95 citations · Cited by this paper
  18. Advanced Lung Cancer Inflammation Index, a New Prognostic Score, Predicts Outcome in Patients With Small-Cell Lung Cancer · Xiaobo He · 2015 · 89 citations · Cited by this paper
  19. Advancements in small cell lung cancer · Jung-Hoon Lee · 2023 · 89 citations · Cited by this paper
  20. Rationale for LDH-targeted cancer immunotherapy · Tina B.S. Miholjcic · 2022 · 87 citations · Cited by this paper
  21. Post-treatment neutrophil-to-lymphocyte ratio (NLR) predicts response to anti-PD-1/PD-L1 antibody in SCLC patients at early phase · Qi Xiong · 2020 · 77 citations · Cited by this paper
  22. Hemoglobin, albumin, lymphocyte, and platelet score and neutrophil-to-lymphocyte ratio are novel significant prognostic factors for patients with small-cell lung cancer undergoing chemotherapy · Feng Qiu · 2020 · 53 citations · Cited by this paper
  23. The clinicopathological and prognostic value of the pretreatment neutrophil-to-lymphocyte ratio in small cell lung cancer: A meta-analysis · Yan Lu · 2020 · 34 citations · Cited by this paper
  24. Predictive biomarkers for immunotherapy response in extensive-stage SCLC · Lin Zhu · 2025 · 33 citations · Cited by this paper
  25. The Relation between Hemogram Parameters and Survival in Extensive-Stage Small Cell Lung Cancer · Abdullah Sakin · 2019 · 32 citations · Cited by this paper
  26. Prognostic roles of hematological indicators for the efficacy and prognosis of immune checkpoint inhibitors in patients with advanced tumors: a retrospective cohort study · Fei Zheng · 2023 · 31 citations · Cited by this paper
  27. Advances in predictive biomarkers associated with immunotherapy in extensive-stage small cell lung cancer · Tong Chen · 2024 · 27 citations · Cited by this paper
  28. The Prognostic Nutritional Index as a Predictor of Gastric Cancer Progression and Recurrence · Kentaro Maejima · 2022 · 26 citations · Cited by this paper
  29. First‐line serplulimab plus chemotherapy in extensive‐stage small‐cell lung cancer: Updated results and biomarker analysis from the ASTRUM‐005 randomized clinical trial · Ying Cheng · 2025 · 23 citations · Cited by this paper
  30. Prognostic value of systemic immune-inflammation index in patients with small-cell lung cancer treated with immune checkpoint inhibitors · Yusuke Hamakawa · 2025 · 15 citations · Cited by this paper
  31. Integration of clinical and blood parameters in risk prognostication for patients receiving immunochemotherapy for extensive stage small cell lung cancer: real-world data from two centers · Xiaomi Li · 2024 · 14 citations · Cited by this paper
  32. Prognostic Nutritional Index Predicts Efficacy and Immune-Related Adverse Events of First-Line Chemoimmunotherapy in Patients with Extensive-Stage Small-Cell Lung Cancer · Baishen Zhang · 2024 · 13 citations · Cited by this paper
  33. Prognostic factors of liver metastases in extensive-stage small cell lung cancer receiving chemo-immunotherapy · Kyoichi Kaira · 2025 · 13 citations · Cited by this paper
  34. Tarlatamab-dlle: A New Hope for Patients with Extensive-Stage Small-Cell Lung Cancer · Parveen Kumar Goyal · 2024 · 12 citations · Cited by this paper
  35. Prognostic Nutritional Index in Patients With End-Stage Oral Cancer · Moeko Momokita · 2022 · 10 citations · Cited by this paper
  36. Prognostic implications of neutrophil‐to‐lymphocyte ratio in patients with extensive‐stage small cell lung cancer receiving chemoimmunotherapy: A multicenter, real‐world study · Huanhuan Bi · 2024 · 10 citations · Cited by this paper
  37. A Systemic Immune Inflammation Index and PD-L1 (SP142) Expression as a Potential Combined Biomarker of the Clinical Benefit of Chemo-Immunotherapy in Extensive-Stage Small-Cell Lung Cancer · Jong Min Baek · 2024 · 10 citations · Cited by this paper
  38. Prognostic value of pretreatment procalcitonin and neutrophil–lymphocyte ratio in extensive-stage small-cell lung cancer · Dongfang Chen · 2024 · 8 citations · Cited by this paper
  39. Navigating first-line therapies for extensive-stage small-cell lung cancer: a frequentist network meta-analysis and systematic review · Ying Liu · 2024 · 8 citations · Cited by this paper

Source: OpenAlex (CC0)